Thrive Capital Management (Pennsylvania)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,081
| Closed | -$290K | – | 184 |
|
|
2023
Q4 | $290K | Sell |
10,081
-3,873
| -28% | -$112K | 0.16% | 104 |
|
|
2023
Q3 | $463K | Buy |
13,954
+180
| +1% | +$5.97K | 0.26% | 66 |
|
|
2023
Q2 | $505K | Buy |
13,774
+1,162
| +9% | +$42.6K | 0.29% | 57 |
|
|
2023
Q1 | $509K | Buy |
12,612
+2,336
| +23% | +$94.3K | 0.32% | 62 |
|
|
2022
Q4 | $527K | Buy |
10,276
+1,439
| +16% | +$73.7K | 0.34% | 59 |
|
|
2022
Q3 | $387K | Buy |
8,837
+2,123
| +32% | +$93K | 0.26% | 68 |
|
|
2022
Q2 | $352K | Buy |
6,714
+1,351
| +25% | +$70.8K | 0.24% | 67 |
|
|
2022
Q1 | $278K | Buy |
5,363
+1,486
| +38% | +$77K | 0.17% | 79 |
|
|
2021
Q4 | $229K | Buy |
+3,877
| New | +$229K | 0.15% | 94 |
|
|
2021
Q3 | – | Sell |
-5,518
| Closed | -$216K | – | 109 |
|
|
2021
Q2 | $216K | Buy |
+5,518
| New | +$216K | 0.17% | 108 |
|